Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Stearidonic Acid-Enriched Buglossoides arvensis Oil Alleviates High-Fat Diet-Induced Hepatic Lipid Accumulation and
Mak-Soon Lee1, Bohyeon Kim2, Jumi Lee2
1Department of Nutritional Science and Food Management, Ewha Womans University, Seoul, Republic of Korea.
Background:
Buglossoides arvensis oil (BO) is rich in plant-based omega-3 polyunsaturated fatty acids (n-3 PUFAs), including stearidonic acid (SDA). Dietary oils enriched with n-3 PUFAs have been shown to exert beneficial effects on inflammation and lipid metabolism; however, the effects of SDA-enriched BO (SBO) remain unclear.
Objectives:
This study aimed to evaluate the effects of SBO (n-3 PUFA: 67.1%, SDA: 38.5%) included in a high-fat (HF; 45% kcal from fat) diet on hepatic lipid accumulation and inflammation.
Methods:
Four-week-old male Sprague-Dawley rats were randomly divided into 3 groups (n = 6/group) and fed different diets for 9 wk: HF, HF with 10% BO (HF + BO), and HF with 10% SBO (HF + SBO) diet groups. At the end of the experiment, we analyzed lipid profiles in the serum and liver; assessed the expression of genes involved in lipid metabolism and inflammation by reverse transcription-quantitative polymerase chain reaction; measured inflammatory cytokines protein concentrations; and evaluated the activity of adenosine monophosphate-activated protein kinase (AMPK), sirtuin 1 (SIRT1), and nuclear factor kappa B (NF-κB).
Results:
HF + SBO group significantly reduced bodyweight and hepatic lipid accumulation compared with HF diet feeding (P < 0.05). Serum and hepatic lipid concentrations were significantly lower, whereas fecal lipid excretion was significantly higher in the HF + SBO group compared with the HF group (P < 0.05). The expression of lipid metabolism-related genes was significantly downregulated in the HF + SBO group, and AMPK and SIRT1 activity were increased 1.53- and 2.28-fold, respectively, compared with the HF group (P < 0.05). BO and SBO intake inhibited NF-κB activation by 27.5% and 41.8%, respectively, and reduced the mRNA and protein expression levels of inflammatory cytokines compared with HF diet feeding (P < 0.05). Moreover, SBO was more effective than BO in this regard.
Conclusions:
These findings suggest that SBO more effectively mitigates hepatic lipid accumulation and inflammation in rats fed HF diet, a phenomenon partly related to the increased activation of AMPK and SIRT1. This indicates that SBO may provide greater benefits than BO in improving lipid metabolism and inflammatory responses.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipid Digestion

